Exosome Technologies Market SWOT Analysis by 2031
MARKET OVERVIEW
Exosomes are small vesicles released by cells containing diverse biomolecules, including proteins, nucleic acids, and lipids. These extracellular vesicles are pivotal for cell-to-cell communication and are present in bodily fluids like blood, urine, and cerebrospinal fluid. Exosomes can be used as biomarkers for disorder diagnosis and monitoring and also can be used as targeted drug delivery systems. The application of exosome technologies has significant potential to advance disease diagnosis, treatment, and scientific research.
The “Global Exosome Technologies Market Analysis to 2031” is a specialized and in-depth study of the medical devices industry with a special focus on global market trend analysis. The report aims to provide an overview of the exosome technologies market with detailed market segmentation by exosome type, application, end user, and geography. The report provides key statistics on the market status of the leading exosome technologies market players and offers key trends and opportunities in the market.
MARKET DRIVERS
Factors driving the exosome technologies market growth are increasing awareness and understanding, advancements in isolation and characterization techniques, and rising prevalence of chronic diseases. However, the high cost of exosome-based products and lack of standardization in isolation, and stringent regulatory needs for approval and commercialization of exosome products are the factors restraining exosome technologies market growth. The rising prevalence of chronic diseases is boosting the market growth. For instance, the International Agency for Research on Cancer (IARC) estimations reveal that globally, around 1 in 5 people develop cancer. Recent estimates show that over 50 million people live within five years of a precedent cancer diagnosis. Also, the high prevalence of skin disorders such as hyperpigmentation or hyper melanosis among people globally as exosomes derived from mesenchymal stem/stromal cell (MSC) cultures shows potential as a next-generation cell-free therapeutic option. In addition, exosome technology market demand will be driven by the increasing need for optimization and innovation of exosome loading capacities and methods to improve target drug efficacy in the coming years. Moreover, changing environmental conditions and human behavior affect the spread and impact of infectious diseases. Thus, the rising prevalence of chronic diseases is fueling the exosome technologies market growth.
GLOBAL SEGMENTAL ANALYSIS
The global exosome technologies market is segmented into exosome type, application, end user. Based on exosome type the market is segmented into loaded cargo and non-cargo. Loaded cargo segment is further sub segmented as peptide, siRNA, mRNA, miRNA, protein, chemical, and others. Further, non-cargo is segmented as HEK293 cells, MSCs, platelets, erythrocytes, natural killer cells, and others. Based on application, the market is segmented into therapeutics and diagnostics. Further, therapeutics segment is further sub segmented as oncology, neurodegenerative diseases, cardiovascular diseases, infectious diseases, cosmetics, and others. The market is segmented into healthcare providers, pharmaceutical & biotechnology companies, and others based on end-user.
Based on the exosome type, the loaded cargo dominates the global exosome technologies market share. The loaded cargo segment had held the largest exosome technologies market share in 2021. This is because the exosome cargo relating to the origin of cells has become much more specific. It is one of the key factors driving the growth of the exosome technologies market, as exosomes are used to transport cargo such as protein, lipids, and nucleic acids between cells, making them a promising tool for drug delivery and biomarker discovery. Thus, the loaded cargo segment drives the growth of the exosome technologies market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides exosome technologies market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The exosome technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & central America after evaluating political, economic, social and technological factors affecting the exosome technologies market in these regions.
North America is anticipated to account for the highest market share in the next few years. The United States is a highly profitable market in the region. Rapidly commercializing exosome products is expected to be driven by increased demand for new cancer treatments and diagnostics. There is a strong expectation of increased market value in North America due to government initiatives designed to promote the production of these products. Global biotech companies in the region are working to scale up the production of therapeutic extracellular vesicles originating from MSC and other stem cells through partnerships with governments and private universities.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides exosome technologies market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The exosome technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & central America after evaluating political, economic, social and technological factors affecting the exosome technologies market in these regions.
North America is anticipated to account for the highest market share in the next few years. The United States is a highly profitable market in the region. Rapidly commercializing exosome products is expected to be driven by increased demand for new cancer treatments and diagnostics. There is a strong expectation of increased market value in North America due to government initiatives designed to promote the production of these products. Global biotech companies in the region are working to scale up the production of therapeutic extracellular vesicles originating from MSC and other stem cells through partnerships with governments and private universities.
MARKET PLAYERS
The report covers key developments in the Exosome Technologies Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the Exosome Technologies Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Exosome Technologies in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Exosome Technologies Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- DANAHER CORP
- PALL CORPORATION
- FUJIFILM HOLDINGS CORP.
- LONZA
- MILTENYI BIOTEC
- BIO-TECHNE CORP.
- QIAGEN
- THERMO FISHER SCIENTIFIC, INC
- ABCAM PLC
- ROOSTERBIO, INC.
Recent Developments
- In November 2021, Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutrition industries, declared the acquisition of the service unit from Exosomics, a leading extracellular vesicles biotech company. The contract shall include Exosomics' Service Team, Services Assets, and Laboratory in Siena, Italy.
- In September 2021, Bio-Techne Corporation and QIAGEN N.V. announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners and the joint development of new exosome-based products.
- In March 2023, RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, today announced that it has selected Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, as a collaboration partner to advance scalable exosome bioprocessing. In collaboration with Repligen, Rooster Biotechnologies shall develop solutions for producing exosomes using Scalable and Low shear Technology, allowing the successful commercialization of these advanced therapies.
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Exosome Technologies Market - By Exosome Type
1.3.2 Exosome Technologies Market - By Application
1.3.3 Exosome Technologies Market - By End-user
1.3.4 Exosome Technologies Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EXOSOME TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EXOSOME TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EXOSOME TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. EXOSOME TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. EXOSOME TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2030
6.3. MARKET POSITIONING
7. EXOSOME TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2030 - EXOSOME TYPE
7.1. OVERVIEW
7.2. EXOSOME TYPE MARKET FORECASTS AND ANALYSIS
7.3. LOADED CARGOS
7.3.1. Overview
7.3.2. Loaded Cargos Market Forecast and Analysis
7.3.3. Peptide Market
7.3.3.1. Overview
7.3.3.2. Peptide Market Forecast and Analysis
7.3.4. siRNA Market
7.3.4.1. Overview
7.3.4.2. siRNA Market Forecast and Analysis
7.3.5. mRNA Market
7.3.5.1. Overview
7.3.5.2. mRNA Market Forecast and Analysis
7.3.6. miRNA Market
7.3.6.1. Overview
7.3.6.2. miRNA Market Forecast and Analysis
7.3.7. Protein Market
7.3.7.1. Overview
7.3.7.2. Protein Market Forecast and Analysis
7.3.8. Chemical Market
7.3.8.1. Overview
7.3.8.2. Chemical Market Forecast and Analysis
7.3.9. Others Market
7.3.9.1. Overview
7.3.9.2. Others Market Forecast and Analysis
7.4. NON-CARGO
7.4.1. Overview
7.4.2. Non-cargo Market Forecast and Analysis
7.4.3. HEK293 Cells Market
7.4.3.1. Overview
7.4.3.2. HEK293 Cells Market Forecast and Analysis
7.4.4. MSCs Market
7.4.4.1. Overview
7.4.4.2. MSCs Market Forecast and Analysis
7.4.5. Platelets Market
7.4.5.1. Overview
7.4.5.2. Platelets Market Forecast and Analysis
7.4.6. Erythrocytes Market
7.4.6.1. Overview
7.4.6.2. Erythrocytes Market Forecast and Analysis
7.4.7. Natural Killer Cells Market
7.4.7.1. Overview
7.4.7.2. Natural Killer Cells Market Forecast and Analysis
7.4.8. Others Market
7.4.8.1. Overview
7.4.8.2. Others Market Forecast and Analysis
8. EXOSOME TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2030 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTICS
8.3.1. Overview
8.3.2. Therapeutics Market Forecast and Analysis
8.3.3. Oncology Market
8.3.3.1. Overview
8.3.3.2. Oncology Market Forecast and Analysis
8.3.4. Neurodegenerative Diseases Market
8.3.4.1. Overview
8.3.4.2. Neurodegenerative Diseases Market Forecast and Analysis
8.3.5. Cardiovascular Diseases Market
8.3.5.1. Overview
8.3.5.2. Cardiovascular Diseases Market Forecast and Analysis
8.3.6. Infectious Diseases Market
8.3.6.1. Overview
8.3.6.2. Infectious Diseases Market Forecast and Analysis
8.3.7. Cosmetics Market
8.3.7.1. Overview
8.3.7.2. Cosmetics Market Forecast and Analysis
8.3.8. Others Market
8.3.8.1. Overview
8.3.8.2. Others Market Forecast and Analysis
8.4. DIAGNOSTICS
8.4.1. Overview
8.4.2. Diagnostics Market Forecast and Analysis
9. EXOSOME TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2030 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HEALTH CARE PROVIDERS
9.3.1. Overview
9.3.2. Health Care Providers Market Forecast and Analysis
9.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4.1. Overview
9.4.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. EXOSOME TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2030 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Exosome Technologies Market Overview
10.1.2 North America Exosome Technologies Market Forecasts and Analysis
10.1.3 North America Exosome Technologies Market Forecasts and Analysis - By Exosome Type
10.1.4 North America Exosome Technologies Market Forecasts and Analysis - By Application
10.1.5 North America Exosome Technologies Market Forecasts and Analysis - By End-user
10.1.6 North America Exosome Technologies Market Forecasts and Analysis - By Countries
10.1.6.1 United States Exosome Technologies Market
10.1.6.1.1 United States Exosome Technologies Market by Exosome Type
10.1.6.1.2 United States Exosome Technologies Market by Application
10.1.6.1.3 United States Exosome Technologies Market by End-user
10.1.6.2 Canada Exosome Technologies Market
10.1.6.2.1 Canada Exosome Technologies Market by Exosome Type
10.1.6.2.2 Canada Exosome Technologies Market by Application
10.1.6.2.3 Canada Exosome Technologies Market by End-user
10.1.6.3 Mexico Exosome Technologies Market
10.1.6.3.1 Mexico Exosome Technologies Market by Exosome Type
10.1.6.3.2 Mexico Exosome Technologies Market by Application
10.1.6.3.3 Mexico Exosome Technologies Market by End-user
10.2. EUROPE
10.2.1 Europe Exosome Technologies Market Overview
10.2.2 Europe Exosome Technologies Market Forecasts and Analysis
10.2.3 Europe Exosome Technologies Market Forecasts and Analysis - By Exosome Type
10.2.4 Europe Exosome Technologies Market Forecasts and Analysis - By Application
10.2.5 Europe Exosome Technologies Market Forecasts and Analysis - By End-user
10.2.6 Europe Exosome Technologies Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Exosome Technologies Market
10.2.6.1.1 Germany Exosome Technologies Market by Exosome Type
10.2.6.1.2 Germany Exosome Technologies Market by Application
10.2.6.1.3 Germany Exosome Technologies Market by End-user
10.2.6.2 France Exosome Technologies Market
10.2.6.2.1 France Exosome Technologies Market by Exosome Type
10.2.6.2.2 France Exosome Technologies Market by Application
10.2.6.2.3 France Exosome Technologies Market by End-user
10.2.6.3 Italy Exosome Technologies Market
10.2.6.3.1 Italy Exosome Technologies Market by Exosome Type
10.2.6.3.2 Italy Exosome Technologies Market by Application
10.2.6.3.3 Italy Exosome Technologies Market by End-user
10.2.6.4 Spain Exosome Technologies Market
10.2.6.4.1 Spain Exosome Technologies Market by Exosome Type
10.2.6.4.2 Spain Exosome Technologies Market by Application
10.2.6.4.3 Spain Exosome Technologies Market by End-user
10.2.6.5 United Kingdom Exosome Technologies Market
10.2.6.5.1 United Kingdom Exosome Technologies Market by Exosome Type
10.2.6.5.2 United Kingdom Exosome Technologies Market by Application
10.2.6.5.3 United Kingdom Exosome Technologies Market by End-user
10.2.6.6 Rest of Europe Exosome Technologies Market
10.2.6.6.1 Rest of Europe Exosome Technologies Market by Exosome Type
10.2.6.6.2 Rest of Europe Exosome Technologies Market by Application
10.2.6.6.3 Rest of Europe Exosome Technologies Market by End-user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Exosome Technologies Market Overview
10.3.2 Asia-Pacific Exosome Technologies Market Forecasts and Analysis
10.3.3 Asia-Pacific Exosome Technologies Market Forecasts and Analysis - By Exosome Type
10.3.4 Asia-Pacific Exosome Technologies Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Exosome Technologies Market Forecasts and Analysis - By End-user
10.3.6 Asia-Pacific Exosome Technologies Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Exosome Technologies Market
10.3.6.1.1 Australia Exosome Technologies Market by Exosome Type
10.3.6.1.2 Australia Exosome Technologies Market by Application
10.3.6.1.3 Australia Exosome Technologies Market by End-user
10.3.6.2 China Exosome Technologies Market
10.3.6.2.1 China Exosome Technologies Market by Exosome Type
10.3.6.2.2 China Exosome Technologies Market by Application
10.3.6.2.3 China Exosome Technologies Market by End-user
10.3.6.3 India Exosome Technologies Market
10.3.6.3.1 India Exosome Technologies Market by Exosome Type
10.3.6.3.2 India Exosome Technologies Market by Application
10.3.6.3.3 India Exosome Technologies Market by End-user
10.3.6.4 Japan Exosome Technologies Market
10.3.6.4.1 Japan Exosome Technologies Market by Exosome Type
10.3.6.4.2 Japan Exosome Technologies Market by Application
10.3.6.4.3 Japan Exosome Technologies Market by End-user
10.3.6.5 South Korea Exosome Technologies Market
10.3.6.5.1 South Korea Exosome Technologies Market by Exosome Type
10.3.6.5.2 South Korea Exosome Technologies Market by Application
10.3.6.5.3 South Korea Exosome Technologies Market by End-user
10.3.6.6 Rest of Asia-Pacific Exosome Technologies Market
10.3.6.6.1 Rest of Asia-Pacific Exosome Technologies Market by Exosome Type
10.3.6.6.2 Rest of Asia-Pacific Exosome Technologies Market by Application
10.3.6.6.3 Rest of Asia-Pacific Exosome Technologies Market by End-user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Exosome Technologies Market Overview
10.4.2 Middle East and Africa Exosome Technologies Market Forecasts and Analysis
10.4.3 Middle East and Africa Exosome Technologies Market Forecasts and Analysis - By Exosome Type
10.4.4 Middle East and Africa Exosome Technologies Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Exosome Technologies Market Forecasts and Analysis - By End-user
10.4.6 Middle East and Africa Exosome Technologies Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Exosome Technologies Market
10.4.6.1.1 South Africa Exosome Technologies Market by Exosome Type
10.4.6.1.2 South Africa Exosome Technologies Market by Application
10.4.6.1.3 South Africa Exosome Technologies Market by End-user
10.4.6.2 Saudi Arabia Exosome Technologies Market
10.4.6.2.1 Saudi Arabia Exosome Technologies Market by Exosome Type
10.4.6.2.2 Saudi Arabia Exosome Technologies Market by Application
10.4.6.2.3 Saudi Arabia Exosome Technologies Market by End-user
10.4.6.3 U.A.E Exosome Technologies Market
10.4.6.3.1 U.A.E Exosome Technologies Market by Exosome Type
10.4.6.3.2 U.A.E Exosome Technologies Market by Application
10.4.6.3.3 U.A.E Exosome Technologies Market by End-user
10.4.6.4 Rest of Middle East and Africa Exosome Technologies Market
10.4.6.4.1 Rest of Middle East and Africa Exosome Technologies Market by Exosome Type
10.4.6.4.2 Rest of Middle East and Africa Exosome Technologies Market by Application
10.4.6.4.3 Rest of Middle East and Africa Exosome Technologies Market by End-user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Exosome Technologies Market Overview
10.5.2 South and Central America Exosome Technologies Market Forecasts and Analysis
10.5.3 South and Central America Exosome Technologies Market Forecasts and Analysis - By Exosome Type
10.5.4 South and Central America Exosome Technologies Market Forecasts and Analysis - By Application
10.5.5 South and Central America Exosome Technologies Market Forecasts and Analysis - By End-user
10.5.6 South and Central America Exosome Technologies Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Exosome Technologies Market
10.5.6.1.1 Brazil Exosome Technologies Market by Exosome Type
10.5.6.1.2 Brazil Exosome Technologies Market by Application
10.5.6.1.3 Brazil Exosome Technologies Market by End-user
10.5.6.2 Argentina Exosome Technologies Market
10.5.6.2.1 Argentina Exosome Technologies Market by Exosome Type
10.5.6.2.2 Argentina Exosome Technologies Market by Application
10.5.6.2.3 Argentina Exosome Technologies Market by End-user
10.5.6.3 Rest of South and Central America Exosome Technologies Market
10.5.6.3.1 Rest of South and Central America Exosome Technologies Market by Exosome Type
10.5.6.3.2 Rest of South and Central America Exosome Technologies Market by Application
10.5.6.3.3 Rest of South and Central America Exosome Technologies Market by End-user
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL EXOSOME TECHNOLOGIES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. EXOSOME TECHNOLOGIES MARKET, KEY COMPANY PROFILES
13.1. DANAHER CORP.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PALL CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. FUJIFILM HOLDINGS CORP.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. LONZA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MILTENYI BIOTEC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BIO-TECHNE CORP.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. QIAGEN
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. THERMO FISHER SCIENTIFIC, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABCAM PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROOSTERBIO, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. DANAHER CORP
2. PALL CORPORATION
3. FUJIFILM HOLDINGS CORP.
4. LONZA
5. MILTENYI BIOTEC
6. BIO-TECHNE CORP.
7. QIAGEN
8. THERMO FISHER SCIENTIFIC, INC
9. ABCAM PLC
10. ROOSTERBIO, INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For